- 专利标题： Drug resistant immunotherapy for treatment of a cancer
-
申请号： US16283669申请日： 2019-02-22
-
公开(公告)号： US10543233B2公开(公告)日： 2020-01-28
- 发明人: Harold Trent Spencer , Anindya Dasgupta , Lawrence S. Lamb
- 申请人： Emory University , The UAB Research Foundation , Children's Healthcare of Atlanta, Inc.
- 申请人地址： US GA Atlanta US AL Birmingham US GA Atlanta
- 专利权人： Emory University,The UAB Research Foundation,Children's Healthcare of Atlanta, Inc.
- 当前专利权人： Emory University,The UAB Research Foundation,Children's Healthcare of Atlanta, Inc.
- 当前专利权人地址： US GA Atlanta US AL Birmingham US GA Atlanta
- 代理机构： Klarquist Sparkman, LLP
- 主分类号： A61K35/37
- IPC分类号： A61K35/37 ; A61K35/17 ; A61K31/4188 ; C12N5/0783 ; A61K31/495 ; A61K31/519 ; A61K35/12
摘要：
The present disclosure is generally related to methods for combining chemotherapy and immunotherapy for the treatment of a cancer. The methods also relate to generating a drug-resistant cytotoxic immune cell line and uses thereof in conjunction with cytotoxic drugs.
公开/授权文献
- US20190175653A1 DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER 公开/授权日：2019-06-13
信息查询
